Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer

Clinical trial NCT07589543 · RECRUITING

Trial details

NCT number: NCT07589543
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum

Start date: 2026-03-02
Primary completion: 2027-03-14
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.